Fragmented Value Chains: The Isolation of Data, Assets, and Innovation

A deep disconnect persists among data providers, asset holders, and downstream applications such as drug discovery, healthcare research, and insurance. Data fails to effectively enhance asset value, while asset-driven insights rarely flow back to reward the data sources that enable them. This broken value chain results in massive inefficiencies, lost opportunities, and slow innovation cycles across the global health economy.